<DOC>
	<DOCNO>NCT03048526</DOCNO>
	<brief_summary>Patients mild moderate dry eye disease randomize receive either NovaTears® Hydrabak® eye drop control .</brief_summary>
	<brief_title>Influence Perfluorohexyloctane ( NovaTears ) Tear Film Thickness Patients With Mild Moderate Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Men woman age 18 year History dry eye disease least 3 month screen visit Be able willing follow instruction , include participation study assessment visit Signed dated write informed consent Have clinically significant slitlamp finding screen visit may include trauma , Steven Johnson syndrome , and/or opinion investigator may interfere study parameter Participation clinical trial 4 week precede screen visit Active ocular allergy ocular allergy expect active study period Pregnancy , plan pregnancy lactate Known hypersensitivity component study medication Any medical surgical history , disorder disease acute chronic severe organic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>